SUMMARY
The rift between pharmacy and industry can block their co-evolution from suppliers of drugs to health care providers. This article identifies key steps that the profession of pharmacy and its industry partners can take to heal the rift and advance mutual interests. One step is to develop a shared agenda for building a personalized risk infrastructure with defined roles for both professionals and companies. A second is for pharmacy leaders to identify how they can collaborate with industry in the Pharma 2029 agenda that shifts all of health care toward preemption and prevention. Patient health can benefit when pharmacy and industry scientifically collaborate in a trusting relationship.